Although K-RAS mutations seem to be associated with the early development of NSCLC, it cannot be excluded that K-RAS mutations are lost later during tumour progression (Burmer and Loeb, 1989; Li et al, 1994). This evidence concerns the gene KRAS and neoplasm.